SEC Form 4 · accession 0001214659-19-000462
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aaron I. Davis
Director · 10% Owner
Period of report
Jan 17, 2019
Accepted (ET)
Jan 22, 2019 · 7:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 37,052 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $64.14 | Jan 17, 2019 | A | 11,000 | A | — | Jan 16, 2029 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.